Cleared Traditional

K942958 - CREATINE KINASE MB DETERMINATION (UV)
(FDA 510(k) Clearance)

Nov 1994
Decision
151d
Days
Class 2
Risk

K942958 is an FDA 510(k) clearance for the CREATINE KINASE MB DETERMINATION (UV). This device is classified as a U.v. Method, Cpk Isoenzymes (Class II - Special Controls, product code JHW).

Submitted by Biochemical Trade, Inc. (Miami, US). The FDA issued a Cleared decision on November 21, 1994, 151 days after receiving the submission on June 23, 1994.

This device falls under the Chemistry FDA review panel. Regulated under 21 CFR 862.1215.

Submission Details

510(k) Number K942958 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 23, 1994
Decision Date November 21, 1994
Days to Decision 151 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Statement

Device Classification

Product Code JHW — U.v. Method, Cpk Isoenzymes
Device Class Class II - Special Controls
CFR Regulation 21 CFR 862.1215

Similar Devices — JHW U.v. Method, Cpk Isoenzymes

All 26
Creatine Kinase-MB
K162526 · Roche Diagnostics · May 2017
ELITECH CLINICAL SYSTEMS ENVOY 500 CK REAGENT KIT
K141265 · Elitechgroup · Jul 2014
ELITECH CLINICAL SYSTEMS CK NAC SL
K122083 · Elitechgroup · Aug 2012
WIENER LAB. CK-MB DS UV UNITEST, MODEL 28 X 2.5 ML CAT. NR. 1271354
K023744 · Wiener Laboratories Saic · Jan 2003
ROCHE DIAGNOSTICS CK-MB
K003158 · Roche Diagnostics Corp. · Dec 2000
ELECSYS CK-MB
K961501 · Boehringer Mannheim Corp. · Jun 1996